• All
  • ARMeD
  • Can-C
  • Cataract
  • Dogs
  • Dry Eye
  • Glaucoma
  • Macular Deg
  • N-acetylcarnosine
  • Nac-C Plus
GlaucomaNac-C Plus
Independent Study finds specific Amino Acids and Anti-Oxidants provide targeted support for those who suffer from IOP and Glaucoma.

This independent study finds that the antioxidants vitamin E and N-acetyl cysteine (NAC) may reduce the progression of glaucoma. Additionally ...

Read More
Can-CCataractN-acetylcarnosine
In clinical test NAC-treated eyes had statistically significant difference in VA, glare sensitivity compared to control at 4-months

1% N-acetylcarnosine (NAC) eye drops were applied topically to the eyes of older drivers. Study results provide a substantial basis ...

Read More
ARMeDMacular Deg
Mechanisms for countering oxidative stress and damage in retinal pigment epithelium

Clinical and experimental evidence supports that chronic oxidative stress is a primary contributing factor to numerous retinal degenerative diseases, such ...

Read More
Can-CCataractN-acetylcarnosine
In study 90.0% of the eyes treated with N-acetylcarnosine, 1% sol (NAC) showed a gradual improvement in b/c VA to 7-100%

Statistical analysis revealed the significant differences over 6 and 24 months in cumulative positive changes of overall characteristics of cataracts ...

Read More
Can-CDry EyeNac-C Plus
Dry eye characterized to have clinically-evident inflammation

Dry Eye type II is has been defined to be characterized by clinically-evident inflammation, and clear evidence of epithelial alterations. ...

Read More
Can-CDry EyeNac-C Plus
Clinical impact of inflammation in dry eye disease

We now have a clearer understanding of the inflammatory processes involved in DED, and there is hope that the still ...

Read More
Showing Slide 1 of 7